Cargando…
Investigating Molecular Signatures Underlying Trapeziometacarpal Osteoarthritis Through the Evaluation of Systemic Cytokine Expression
PURPOSE: Non-operative management of trapeziometacarpal osteoarthritis (TMOA) demonstrates only short-term symptomatic alleviation, and no approved disease modifying drugs exist to treat this condition. A key issue in these patients is that radiographic disease severity can be discordant with patien...
Autores principales: | Ratneswaran, Anusha, Rockel, Jason S., Antflek, Daniel, Matelski, John J., Shestopaloff, Konstantin, Kapoor, Mohit, Baltzer, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814933/ https://www.ncbi.nlm.nih.gov/pubmed/35126358 http://dx.doi.org/10.3389/fimmu.2021.794792 |
Ejemplares similares
-
Abstract 138: Cytokine Expression In Trapeziometacarpal Osteoarthritis: Predicting Prognosis, Progression And Treatment
por: Baltzer, Heather L., et al.
Publicado: (2020) -
Minimal clinically important difference of the Trapeziometacarpal Arthrosis Symptoms and Disability questionnaire
por: Florczynski, Matthew, et al.
Publicado: (2022) -
A classification modeling approach for determining metabolite signatures in osteoarthritis
por: Rockel, Jason S., et al.
Publicado: (2018) -
The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology
por: Rockel, Jason S., et al.
Publicado: (2018) -
Effect of autotaxin inhibition in a surgically-induced mouse model of osteoarthritis
por: Datta, Poulami, et al.
Publicado: (2020)